Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wallis

Showing results (211-220 of 506) with videos related to

Pageof 51
Sort By:
British Journal of Clinical Pharmacology|January 1, 1979
Single daily dose treatment of anxiety with clobazam or dipotassium clorazepateT D Wallis, J C Vallé-Jones, J R Craven, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 10, 2025
Association of race and 30-day postoperative complications after urologic oncology surgeryAlex B Bak, Keiran J C Pace, Bruce Gao, et al.
European Urology|October 6, 2019
Effect of Renal Mass Biopsy on Subsequent Nephrectomy Outcomes: A Population-based AssessmentChristopher J D Wallis, Alaina Garbens, Zachary Klaassen, et al.
Urology Practice|March 14, 2025
Treatment Delays in the Hispanic Population With Renal Cell Carcinoma: An Analysis of Over 150,000 Patients Using the National Cancer DatabaseVatsala Mundra, Zachary Melchiode, Jiaqiong Xu, et al.
Beilstein Journal of Organic Chemistry|December 15, 2015
Synthesis of racemic and chiral BEDT-TTF derivatives possessing hydroxy groups and their achiral and chiral charge transfer complexesSara Jane Krivickas, Chiho Hashimoto, Junya Yoshida, et al.
Organic & Biomolecular Chemistry|September 20, 2007
Synthesis of bis(ethylenedithio)tetrathiafulvalene (BEDT-TTF) derivatives functionalised with two, four or eight hydroxyl groupsR James Brown, Andrew C Brooks, Jon-Paul Griffiths, et al.
European Urology Oncology|May 19, 2019
Advanced Androgen Blockage in Nonmetastatic Castration-resistant Prostate Cancer: An Indirect Comparison of Apalutamide and EnzalutamideChristopher J D Wallis, Thenappan Chandrasekar, Hanan Goldberg, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 16, 2020
Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment DecisionsRana R McKay, Felix Y Feng, Alice Y Wang, et al.
Journal of Cancer|December 8, 2015
MiR-182 Is Associated with Growth, Migration and Invasion in Prostate Cancer via Suppression of FOXO1Christopher J D Wallis, Aida Gordanpour, Jessica Stojcic Bendavid, et al.
The Prostate|July 4, 2019
MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXLRobert K Nam, Tania Benatar, Christopher J D Wallis, et al.
Pageof 51

Showing results (211-220 of 506) with videos related to

Sort By:
Pageof 51
British Journal of Clinical Pharmacology|January 1, 1979
Single daily dose treatment of anxiety with clobazam or dipotassium clorazepateT D Wallis, J C Vallé-Jones, J R Craven, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 10, 2025
Association of race and 30-day postoperative complications after urologic oncology surgeryAlex B Bak, Keiran J C Pace, Bruce Gao, et al.
European Urology|October 6, 2019
Effect of Renal Mass Biopsy on Subsequent Nephrectomy Outcomes: A Population-based AssessmentChristopher J D Wallis, Alaina Garbens, Zachary Klaassen, et al.
Urology Practice|March 14, 2025
Treatment Delays in the Hispanic Population With Renal Cell Carcinoma: An Analysis of Over 150,000 Patients Using the National Cancer DatabaseVatsala Mundra, Zachary Melchiode, Jiaqiong Xu, et al.
Beilstein Journal of Organic Chemistry|December 15, 2015
Synthesis of racemic and chiral BEDT-TTF derivatives possessing hydroxy groups and their achiral and chiral charge transfer complexesSara Jane Krivickas, Chiho Hashimoto, Junya Yoshida, et al.
Organic & Biomolecular Chemistry|September 20, 2007
Synthesis of bis(ethylenedithio)tetrathiafulvalene (BEDT-TTF) derivatives functionalised with two, four or eight hydroxyl groupsR James Brown, Andrew C Brooks, Jon-Paul Griffiths, et al.
European Urology Oncology|May 19, 2019
Advanced Androgen Blockage in Nonmetastatic Castration-resistant Prostate Cancer: An Indirect Comparison of Apalutamide and EnzalutamideChristopher J D Wallis, Thenappan Chandrasekar, Hanan Goldberg, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 16, 2020
Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment DecisionsRana R McKay, Felix Y Feng, Alice Y Wang, et al.
Journal of Cancer|December 8, 2015
MiR-182 Is Associated with Growth, Migration and Invasion in Prostate Cancer via Suppression of FOXO1Christopher J D Wallis, Aida Gordanpour, Jessica Stojcic Bendavid, et al.
The Prostate|July 4, 2019
MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXLRobert K Nam, Tania Benatar, Christopher J D Wallis, et al.
Pageof 51